Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,811,894
+$1,263,072 QoQ
Shares Held
27,070
+6.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,127
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caldwell Trust Co holds $66,282,067 across 15 Drug Manufacturers - General names. ABBV ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,550 | $25,847,718 | |
| 2 | JNJ |
Johnson & Johnson
|
56,485 | $14,345,495 | |
| 3 | AMGN |
Amgen Inc
|
26,584 | $9,626,598 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
27,070 | $6,811,894 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,474 | $4,558,408 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
30,189 | $1,739,490 | |
| 7 | AZN |
Astrazeneca PLC
|
8,454 | $1,603,047 | |
| 8 | PFE |
Pfizer Inc
|
44,139 | $1,062,867 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,811,894 | 27,070 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,548,822 | 25,513 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $5,586,352 | 24,449 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $5,785,953 | 24,989 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $4,660,918 | 25,110 | Shares | Sole | 2025-09-22 | |
| 2025-03-31 | $5,102,021 | 24,351 | Shares | Sole | 2025-09-23 | |
| 2024-12-31 | $4,283,813 | 24,107 | Shares | Sole | 2025-09-24 | |
| 2024-09-30 | $5,028,433 | 25,463 | Shares | Sole | 2025-09-24 | |
| 2024-06-30 | $4,275,136 | 24,925 | Shares | Sole | 2025-09-24 | |
| 2024-03-31 | $4,627,525 | 25,412 | Shares | Sole | 2025-09-24 | |
| 2023-12-31 | $3,989,857 | 25,746 | Shares | Sole | 2025-10-01 | |
| 2023-09-30 | $4,289,797 | 28,779 | Shares | Sole | 2025-10-01 | |
| 2023-06-30 | $4,241,030 | 31,478 | Shares | Sole | 2025-10-01 | |
| 2023-03-31 | $4,993,540 | 31,333 | Shares | Sole | 2025-10-01 | |
| 2022-12-31 | $5,091,199 | 31,503 | Shares | Sole | 2025-10-01 | |
| 2022-09-30 | $4,493,082 | 33,478 | Shares | Sole | 2025-10-01 | |
| 2022-06-30 | $5,275,596 | 34,445 | Shares | Sole | 2025-10-02 | |
| 2022-03-31 | $5,628,945 | 34,723 | Shares | Sole | 2025-10-02 | |
| 2021-12-31 | $4,711,513 | 34,797 | Shares | Sole | 2025-10-02 | |
| 2021-09-30 | $3,778,578 | 35,029 | Shares | Sole | 2025-10-02 | |
| 2021-06-30 | $3,793,602 | 33,679 | Shares | Sole | 2025-10-02 | |
| 2021-03-31 | $3,667,251 | 33,887 | Shares | Sole | 2025-10-02 | |
| 2020-12-31 | $3,598,954 | 33,588 | Shares | Sole | 2025-10-02 | |
| 2020-09-30 | $2,891,608 | 33,013 | Shares | Sole | 2025-10-02 | |
| 2020-06-30 | $3,326,043 | 33,877 | Shares | Sole | 2025-10-02 | |
| 2020-03-31 | $2,542,155 | 33,366 | Shares | Sole | 2025-10-02 | |
| No filing history on record for this holder in this stock. | ||||||